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STUDIES ON BACTERIAL POLYSACCHARIDES OF BIOTECHNOLOGICAL INTEREST 
 
Abstract 
 
The ability to produce polysaccharides is widely found among microbial species, especially among 
prokaryotes. Large numbers of bacterial polysaccharides are potentially available, but relatively few have 
been commercially employed. The bacteria may be pathogenic, production costs may be very high, product 
quality may be difficult to maintain and to guarantee, or the product may not achieve regulatory 
acceptability. Despite these problems, several products from bacteria are accepted products for modern 
biotechnology: for instance, many sectors of industry are showing a growing interest for microbial 
polysaccharides, usually associated with the outer surface of the bacterium. They can form an amorphous 
layer of extracellular polysaccharides (EPSs) surrounding the cell that may be further organized into a distinct 
structure termed a capsule. Additional polysaccharide molecules such as lipopolysaccharide (LPS) or 
lipooligosaccharide (LOS) may also decorate the cell surface. Polysaccharide capsules may mediate a 
number of biological processes, including invasive infections of human beings. LPSs are found in the outer 
membrane of the Gram-negative bacteria and they are also known as endotoxins (Fig. 1). 
 They consist of three parts: lipid A, which is the toxic component; 
the core region, which can be divided into an inner and an 
outer part; and finally the O-antigen polysaccharide, which is 
specific for each serogroup.  
Fig. 1 
Considerable attention is now paid to the bacteria Escherichia coli, Agrobacterium tumefaciens and 
Lactobacillus. The first two are Gram-negative bacteria, some strains of  E. coli produce EPSs that warrant 
special notice because they bear close structural relationship to polymers of the human host, whereas A. 
tumefaciens is a bacterium important for plant bioengineering. The last one, Lactobacillus, is a Gram-positive 
bacterium which produces EPSs commonly used by the food industry - mainly because of their GRAS 
(generally regarded as safe) status. Furthermore, EPSs from LAB (Lactic Acid Bacteria) have received 
increasing interest from pharmaceutical companies due to their potential use as probiotics. The target of this 
research deals with the structure and the structure/function analysis of microbial polysaccharides with 
potential biotechnological interest. The following strains have been selected: 
 
- Escherichia coli O5:K4:H4 
- Agrobacterium tumefaciens A1, F/1, TT9, and TT111 
- Lactobacillus crispatus B6    
 
 
Escherichia coli O5:K4:H4 
 
E. coli O5:K4:H4 synthesizes a capsule polysaccharide (K4 antigen) with a carbohydrate backbone similar to 
non sulphated chondroitin. The K4 antigen is composed of a repeating subunit made of D-glucuronic acid 
(GlcA), N-acetyl-D-galactosamine (GalNAc) and β-fructofuranose (Fru) (1): 
[GlcA-β-(1→3)-GalNAc-β(1→4)]n 
 3 
 ↑ 
 1 
 β-Fru 
This repetitive unit presents a structural analogy with chondroitin sulphate [(D-GlcA β(1-3)-D-GalNAc β(1-4)]n. 
Chondroitin sulfate differs from K4 polymer for the presence of the fructofuranose residue and for the lack of 
sulphate. Human chondroitin is mostly sulphated at positions 4 or 6 of N-acetyl galactosamine, although rare 
substitutions at O-2 or O-3 of the uronic acid may happen. Chondroitin sulfate is a substance found naturally in 
the human body: it is part of a large protein molecule (proteoglycan) that gives cartilage elasticity. The 
commercial preparation is extracted from animal tissues such as pig tracheas or shark fins and it is sold as 
dietary or nutritional supplement. Under such circumstances it is of great interest to have a procedure that 
rapidly could defructosylate the native K4 and purify it from the toxic LPS so to obtain a suitable product that 
could be further sulphated in the desired positions. In order to set up a purification protocol suitable for an 
industrial scale up process, different methods have been tested to develop a viable commercial process 
economically advantageous and ecologically compatible. The K4 polysaccharide was obtained by 
fermentation, isolated from broth culture. Different types of media were tried and tested to achieve an 
optimal fermentation yield. Chemical analysis and NMR spectra showed K4 to be always present together with 
the LPS molecule; fructose from K4 and lipid A from LPS were removed by mild acid hydrolysis, so that the 
resulting O-Chain and defructosilated K4 could be separated by anion-exchange chromatography on a Q-
Sepharose FF resin. This purification method opens up new prospects for obtaining biologically active 
molecules by semi-synthesis as an alternative to extraction from animal organs. 
 
Agrobacterium tumefaciens A1, TT111, F1, and TT9 
 
The bacteria belonging to A. tumefaciens species are object of very intensive investigation due to their 
potential biotechnology use. All the members of this family are phytopathogenic and induce the crown gall 
disease in most of dicotyledonous plants(2). The disease is characterized by neoplastic transformation at the 
site of infection and it results from the transfer and expression of oncogenes from bacteria to susceptible plant 
cells. The utility of these bacteria has developed from an understanding of the molecular basis of the disease 
symptoms: the transfer of a small portion of DNA (T-DNA or transferred DNA) from the bacterium to the plant 
nuclear genome. The O-antigenic region of LPS is primarily responsible for the serological specificity of the 
organisms (Wilkinson, 1977) and thus it may be reasonable to assume that these exposed carbohydrates might 
play a major role in the adherence of Agrobacterium to the plant cells. This peculiar feature makes them 
suitable tools for plant genetic engineering: replacing the transferred tumour-inducing genes with exogenous 
DNA allows the introduction of any desired gene into the plant. Thus, A. tumefaciens has been critical for the 
development of modern plant genetics and agricultural biotechnology. Bacteria can express either smooth 
LPS, which is composed of O-antigen, complete core oligosaccharides, and the lipid A, or rough LPS (LOS) 
which lack O-antigen but possesses lipid A and progressively shorter core oligosaccharides. The structure of the 
LPS or LOS fractions of four different strains of A. tumefaciens have been determined using NMR, GC-MS and 
Oligosaccharide 1 
chemical analysis in order to clarify the involvement of these carbohydrate groups in host-pathogen 
interaction.  
 
A. tumefaciens A1      
 
A. tumefaciens strain A1 presents a LOS fraction composed of three different oligosaccharide structures. 
Oligosaccharide 1 represents the most complex structure, in which the external Kdo ( 3-deoxy-D-manno-2-
octulosonic acid) bears a galactose (Gal), while the mannose residue (Man) linked to the internal Kdo bears 
an additional mannose: 
α-D-Man 
1 
↓ 
6 
α-D-Man-(1→5)-α-D-Kdo-(2→6)-β-D-GlcN4P-(1→6)-α-D-GlcN1P                                                           Oligosaccharide 1 
 4 
 ↑ 
 2 
β-D-Gal-(1→8) α-D-Kdo 
 
Oligosaccharide 2 is very similar to oligosaccharide 1: it maintains  the terminal galactose on the external Kdo, 
but there are no additional mannose residues: 
 
α-D-Man-(1→5)-α-D-Kdo-(2→6)-β-D-GlcN4P-(1→6)-α-D-GlcN1P 
 4                                                                                                                                 Oligosaccharide 2 
 ↑ 
 2 
β-D-Gal-(1→8) α-D-Kdo 
 
Oligosaccharide 3 differs from oligosaccharide 2 by lacking the terminal galactose unit: 
 
α-D-Man-(1→5)-α-D-Kdo-(2→6)-β-D-GlcN4P-(1→6)-α-D-GlcN1P 
 4 
 ↑                                                                                                                                  Oligosaccharide 3 
 2 
  α-D-Kdo 
 
 
 
 
A. tumefaciens TT111 
 
The LOS fraction from the phytopathogenic bacterium A. tumefaciens TT111, the reference strain for the 
homonymous group, is composed of four different oligosaccharides. These species descend from a common 
architecture, oligosaccharide 1, further substituted from the non stoichiometric residues R1 (α-Rha) and R2 (β-
GlcN): 
R2→3)-α-Rha-(1→2)-α-Rha-(1→2)-α-Rha-(1→3)-α-Rha-(1→3)-α-Man-(1→5)-α-Kdo-(2→6)-β-GlcN4P-(1→6)-α-GlcN1P 
 4  
 ↑  
 2  
 β-Gal-(1→8)-α-Kdo 
 4 
 ↑ 
 1 
 β-Gal(2←R1 
 
 
                                                                                                           
Fig. 2 
A. tumefaciens F1 
 
A. tumefaciens F1 is a smooth-type bacterium. Its LPS fraction presents two different O-Chains, obtained by 
mild acid hydrolysis of the lipopolysaccharides. Their structures were determined by chemical analyses and 
NMR spectroscopy. The repeating units are reported here: 
 
[3)-α-L-Rhap-(1 →3)-β-D-GlcpNAc-(1→]n   O-Chain 1 (less abundant) 
 
[4)- α-L-Rhap-(1 →3)- β-D-GlcpNAc-(1→]n  O-Chain 2 (major component) 
 
The only difference between the two structures concerns the rhamnose, which in O-Chain 1 is 3-O linked while 
in O-Chain 2 is 4-O linked.  
 
A. tumefaciens TT9 
 
LPS fraction from strain TT9 comprehends two different antigenic moieties, the simplest one is a linear 
polysaccharide with the following repeating unit: 
[4)-α-L-Rha-(1→3)-α-D-Fuc-(1→]n 
By means of extensive chemical procedures the identification of the repeating unit of the second polymer 
(Fig. 2) was achieved; it is constituted from the amino acid N-methyl-3,4-dihydroxy-3-methyl-5-oxoproline and 
from the sugar residue 4-deoxy-4-amino-3-O-methyl-α-D-Fucose; the 
monosaccharide is linked at O-4 of the modified amino acid that, in 
turn, is a substituent at N-4 of the successive amino sugar unit.  
 
                                                                                                                            
                                                                                                                                        
 
 
 
 
 
 
Conclusions 
A.tumefaciens strains A1 and TT111, although belonging to the same TT111 group, differ in pathogenicity. In 
particular, strain A1 is not a very pathogenic one even if compared to the other strains belonging to this group. 
The difference in the pathogenic profile can be correlated to the differences present in the structures: A1 
oligosaccharides contain hexoses but no deoxysugars such as rhamnose or fucose, usually present in both LOS 
or LPS structures from other members of the genus Agrobacterium. These results suggest that deoxysugars 
residues, more stable and more hydrophobic than hexoses, may contribute to the pathogenicity of bacteria 
by supporting the adhesion process during the infection. Another characteristic feature of strain A1 is the very 
low molecular mass of its LOS fraction: the number of sugar residues varies from 5 to 7, while TT111 
oligosaccharides 1 is built up of  13 units. In addition, it is worthy of note that the outer core region of strain 
TT111 is composed of a rhamnose oligosaccharide that shares sequences and conformational similarities with 
some bioactive rhamnans already tested and proposed as epitope necessary for the recognition mechanism 
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involved during the infection process(10). As for strain TT9 and strain F1, they both present carbohydrate residues 
attached to lipids as lipopolysaccharides on the outer membrane of the bacteria. Strain F1 produces two O-
Chains with almost the same structure. Surprisingly, these two structures have been shown to be identical to 
the  structures of the polysaccharides from serotypes O17 and O19 (for the minor component) and O1 (for the 
major component) from Serratia marcescens(11). S. marcescens is a Gram-negative rod which can cause 
endotoxin shock when a number of bacteria invade the bloodstream. Pathogenicity of these bacteria is due, 
among other factors, to the presence of LPS in their cell wall. There is evidence for a close structure/function 
relationship among these O-Chains belonging to two bacteria from very different families (S. marcescens 
belongs to Enterobacteriaceae family and A. tumefaciens to Rhizobiaceae). Strain TT9 produces two O-
Chains as well, one with a simple disaccharidic repeating unit and another one which is found for the first time 
in bacterial LPS. The structure of the oxoproline derivative is new and it participates to the glycosidic linkage 
formation as well. This feature is really peculiar, since it is quite uncommon for a glycosidic linkage to join a 
sugar moiety and a modified amino acid. Elucidation of such unusual structural peculiarities may lead to 
understanding of biological properties of this pathogenic bacterium. 
 
Lactobacillus crispatus B6 
 
The Lactic Acid Bacteria (LAB) comprise a clade of gram positive, acid tolerant, non-sporulating, rod or cocci 
that are associated by their common metabolic and physiological characteristics. These bacteria produce 
lactic acid as the major metabolic end product of carbohydrate fermentation. This trait has historically linked 
LAB with food fermentation as acidification inhibits the growth of spoilage agents. Lactobacillus is a genus of 
Gram-positive facultative anaerobe bacteria; they are a major part of the Lactic Acid Bacteria group. They 
are common and usually benign, even necessary, inhabitants of humans and other animals. In humans they 
are present in the vagina (3) and in the gastrointestinal tract and are an important genus of the gut flora. It has 
been suggested that these properties and some antagonistic mechanisms may include competitive 
interference in pathogen adhesion(4), capability to aggregate with other bacteria(5), and production of 
antibiotic-like substances or hydrogen peroxide(6). The function of lactobacilli is to maintain an acidic 
environment which inhibits the growth of some harmful bacteria. Their metabolic products can improve the 
microflora of the host and also to stimulate the immune system. Because HIV is readily inactivated below pH 
4.5, a number of acidifying agents (often called microbicides) are in development for use as topical 
prevention(7). There are different ways in which microbicides act to prevent infection with genital pathogens. 
Some microbicides (Carraguard®, Cyanoviran®, cellulose sulphate, PRO 2000®) provide a physical barrier that 
keeps HIV and other pathogens from reaching the target cells. Another class of microbicides (e.g. Acidform®, 
BufferGel® and Lactobacillus crispatus) act by enhancing the natural vaginal defence mechanisms by 
maintaining an acidic pH, which protects the vagina(8). Following this pipeline, a clinically isolated strain of  L. 
crispatus (namely L. C. strain B6) has been characterised and the structure of the EPS produced has been 
elucidated. Chemical analyses together with  NMR data allowed to suggest an average repeating unit built 
up of mannose α(1→6) backbone highly branched at C-2 with di-, tri- and tetrasaccharide side chains as here 
reported: 
 
 
 
 
 
[→6)α-D-Manp-(1→6)-α-D-Manp-(1→6)-α-D-Manp-(1→6)-α- D-Manp-(1→]n 
 2 2 2  
 ↑ ↑ ↑ 
 1 1 1 
α-D-Manp  α-D-Manp  α-D-Manp 
                                       2 2  
                                       ↑ ↑  
                                       1 1  
                                 α-D-Manp α-D-Manp  
 3 
 ↑ 
 1 
 α-D-Manp 
 
 
 
It is noteworthy that there is evidence that mannan can block dendritic cell uptake of HIV in vitro(9). The 
structural characterisation of this exopolysaccharide will add new information necessary to direct the further 
development and refinement of strategies that will ultimately provide effective protection against mucosal 
HIV transmission. 
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CHAPTER 1 
 
BACTERIAL POLYSACCHARIDES 
 
1.1.       Introduction 
  
Bacteria produce a variety of polysaccharides as part of their cell wall, which are usually 
associated with the outer surface of the bacterium, but bacteria can produce both 
surface and/or secreted polysaccharides that can act as prominent antigens. Many of 
these polysaccharides are also extremely variable in structure, function and biosynthesis, 
as shown for Salmonella and E. coli. As in other Gram-negative bacteria, the E. coli cell 
wall consists of an inner and an outer membrane separated by a periplasmic space. 
Peptidoglycan, a polysaccharide covalently linked to short peptides, represents the major 
structural component of the periplasm (Fig. 1.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.1. Structure of the cell wall in E. coli.  
The cell wall of gram-negative bacteria consists of several layers of various polysaccharides. The 
periplasm contains Peptidoglycan, a copolymer of polysaccharide and short peptides, and a class 
of β-glucans known as MDOs which play a part in osmoregulation. The outer leaflet of the outer 
membrane is rich in LPS. In mucoid strains, a capsular polysaccharide covers the entire cell (not 
shown). 
 
 
Gram-positive bacteria have a similar cell wall structure, except that they lack the outer 
membrane and have a much thicker peptidoglycan layer with additional specialized 
polysaccharides known as teichoic acids. Bacterial polysaccharides include 
lipopolysaccharides (LPSs), lipooligosaccharides (LOSs), capsular polysaccharides (CPSs) 
and extracellular polysaccharides (EPSs). Some bacteria can form an amorphous layer of 
EPSs surrounding the cell that may be further organized into a distinct structure termed 
capsule. LPS (Fig. 1.2) is present only in Gram-negative bacteria and, structurally, in its 
smooth form, it comprises three regions: lipid A, Core oligosaccharide and O-antigen (O-
Chain).  
 
 
 
 
 
Fig. 1.2. Schematic structure of LPS in E. coli.  
The lipid A domain contains two acylated GlcNAc-P residues (G). The core domain consists of KDO 
(K), heptoses (H), and neutral sugars such as galactose. The outer O-antigen consists of units of two 
to eight sugars repeated many times (open hexagons). 
 
The lipid A component is composed of sugars and fatty acids, which anchor the LPS in the 
outer leaflet of the outer membrane. The core is made of sugars and unusual sugars 
derivatives, such as 3-deoxy-D-manno-octulosonic (Kdo). The O-antigen is a 
polysaccharide that extends from the cell surface and it consists of repeating 
oligosaccharide units. LPSs in their rough form do not possess an O-specific polysaccharide 
and are named LOSs(1). In pathogenic bacteria, capsular EPSs and O-antigen 
lipopolysaccharides are involved in the immune response: they represent the first line of 
defence against bacteriophages. Polysaccharide capsules may mediate a number of 
biological processes, including invasive infections of human beings. The capsular 
polysaccharides and LPS also contain the major antigenic determinants that distinguish 
various serotypes of bacteria, which are sometimes correlated with disease. EPSs 
produced by lactic acid bacteria (LAB) display a great variety of structures, and many are 
heteropolysaccharides composed of different sugar moieties. In addition to their 
technological properties in fermented milk products, they may also have biological roles, 
such as immunomodulatory and cholesterol-lowering activities. Furthermore, EPSs 
produced by some LAB are currently used as microbicides: preliminary studies using 
Lactobacillus for normalization of the vaginal flora showed it to be of great potential 
benefit. Lactobacilli can effectively decrease the risk of bacterial vaginosis and enhance 
resistance to sexually transmitted infections, providing effective protection against 
mucosal HIV transmission. As polysaccharide structure has a great influence on the 
technological properties and biological activities of EPSs, identification of new structures 
will add new information to further develop their use.    
 
 
 
 
 
 
1.2.        Lipopolysaccharides : structure, occurrence and biology 
 
As briefly described above, the envelope of Gram-negative bacteria is composed of two 
distinct lipid membranes: an inner membrane and an outer membrane. The outer 
membrane is an asymmetric bilayer, the outer leaflet of which consist predominantly of 
lipopolysaccharides with proteins taking up much of the remaining surface. The inner 
leaflet is composed simply of conventional glycerophospholipids, mainly 
phosphatidylethanolamine and phospatidylglycerol. The outer membrane has an 
important function in nutrient uptake but also provides the organisms with remarkable 
permeability barriers that confer resistance to many different detergent and antibiotics. 
LPS  was first discovered more than 100 years ago: in 1892-95, Richard Pfeiffer, while 
investigating V. cholerae identified two different toxic factors: a heat-liable exotoxin 
released during growth and a heat-stable endotoxin released during stationary phase. The 
term endotoxin does not appear in Pfeiffer publications, but is cited in 1904 review article 
by Wolff referring to Pfeiffer coining the term.  When released into the circulation, it binds 
to CD14 on monocytes and macrophages, which triggers secretion of various cytokines. Its 
structure is complex, consisting of three distinct domains termed lipid A, core and O-Chain. 
The biosynthesis of LPS is strictly sequential. The core sugars are added sequentially to Lipid 
A by successive additions, and the O side chain is added last, one preassembled subunit 
at a time. The properties of mutants producing incomplete LPS molecules suggests the 
nature and biological functions performed by various parts of the LPS molecule. 
 
 
 
1.2.1. Lipid A 
 
Lipid A is a unique and distinctive phosphoglycolipid, the structure of which is highly 
conserved among species. The partial structure was described in 1950s but remained 
uncertain until 1983 (Rif.11 di Alba). The complete synthesis of lipid A in 1985 confirmed its 
identity as the heat-stabile endotoxin associated with Gram-negative sepsis. Lipid A also 
serves to anchor LPS to the cell surface by insertion into the outer membrane and as the 
scaffold for assembly of the inner core region and the outer O-antigens oligosaccharides. 
The basic structure of lipid A consists of two phosphorylated N-acetyl-glucosamine residues 
in β(1-6) linkage with 4 or 7 fatty acids attached. The length of the carbon chains usually 
varies between C10 and C16, with some exceptions. E. coli lipid A, as an example, 
typically has five C14 and one C12. Lipid A is a very potent stimulant of the immune 
system, activating cells involved in the immune response (monocytes or macrophages) at 
picogram per milliliter quantities. It is believed to activate cells via Toll-like receptor 4 
(TLR4), MD-2 and CD14 on the cell surface. When present in the body at high 
concentrations during a Gram-negative bacterial infection, it may cause shock and death 
by an excessive immune reaction.  
 
 
1.2.2. Lipid A and virulence 
 
Endotoxins are toxic to most mammals. Compared to the classic exotoxins of bacteria, 
endotoxins are less potent and less specific in their action, since they do not act 
enzymatically. Endotoxins are heat stable (boiling for 30 minutes does not destabilize 
endotoxin), but certain powerful oxidizing agents such as superoxide, peroxide and 
hypochlorite degrade them. The injection of living or killed Gram-negative cells, or purified 
LPS, into experimental animals causes a wide spectrum of nonspecific pathophysiological 
reactions such as: fever, changes in white blood cell counts, disseminated intravascular 
coagulation, hypotension, shock and death. Lipid A is the region of LPS mainly responsible 
for many of the pathophysiological effects associated with infection by Gram-negative 
bacteria, although this activity may be modulated by the nature of the polysaccharide 
core region. Since Lipid A is embedded in the outer membrane of bacterial cells, it 
probably exerts its toxic effects only when released from multiplying cells in a soluble form, 
or when the bacteria are lysed as a result of autolysis, complement and the membrane 
attack complex, ingestion and killing by phagocytes, or killing with certain types of 
antibiotics. It is thought that LPS released into the bloodstream by lysing Gram-negative 
bacteria is first bound by certain plasma proteins identified as LPS-binding proteins. The 
LPS-binding protein complex interacts with CD14 receptors on monocytes and 
macrophages and other types of receptors on endothelial cells. In monocytes and 
macrophages three types of events are triggered during their interaction with LPS:  
a. Production of cytokines, including IL-1, IL-6, IL-8, tumour necrosis factor (TNF) and 
platelet-activating factor. These in turn stimulate production of prostaglandins and 
leukotrienes. These are powerful mediators of inflammation and septic shock that 
accompanies endotoxin toxemia. LPS activates macrophages to enhanced phagocytosis 
and cytotoxicity. Macrophages are stimulated to produce and release lysosomal 
enzymes, IL-1, and tumour necrosis factor (TNF-alpha), as well as other cytokines and 
mediators. 
b. Activation of the complement cascade. C3a and C5a cause histamine release 
(leading to vasodilatation) and effect neutrophil chemotaxis and accumulation. The result 
is inflammation. 
c. Activation of the blood coagulation cascade.  Initial activation of Hageman factor 
(blood-clotting Factor XII)  can activate several humoral systems resulting in coagulation, 
activation of the complement alternative pathway, plasmin activation which leads to 
fibrinolysis, kinin activation releases bradykinins and other vasoactive peptides which 
causes hypotension. The net effect is to induce inflammation, intravascular coagulation, 
haemorrhage and shock.  
 
1.2.3. Core Region 
The core oligosaccharide is expressed by all Gram-negative bacteria and is a functionally 
important part of the LPS. The core region consists of two domains, the outer core (O-
polysaccharide proximal)and the inner core (lipid A proximal). The core region usually 
demonstrates little structural variability within a bacterial species, e.g. E. coli has five core 
types. Importantly, the greater structural differences among the core regions of various 
bacterial species occur primarily in the outer core region. The core region from both 
smooth and rough forms of enteric bacteria generally includes oligosaccharides built of up 
to 11 units. The inner core region is characterised by the presence of the unusual sugars L-
glycero-D-manno-heptose (Hep) and 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo). Linking 
the reducing end of the inner core region with lipid A is an α-ketosidic Kdo residue, termed 
Kdo I. Kdo I is further substituted by an α-linked Kdo [Kdo II], which in turn may be non-
stoichiometrically substituted by another Kdo [Kdo III]. A Hep residue is usually attached to 
Kdo I and this may be substituted by another Hep residue to which the outer core region is 
attached. The inner core region may also have other monosaccharides or charged 
entities such as phosphate and ethanolamine. The inner core may play a role in 
modulating lipid A activity and in the induction of cytokines such as IL-1. Furthermore, this 
region represents the high affinity binding site for divalent cations of importance in 
maintaining outer membrane integrity of some bacterial species. 
 
1.2.4.  O-polysaccharide (O-Chain) 
O-Chain is attached to the Outer Core oligosaccharide. It is composed of up to 40 
repeating units, which may contain up to 7 different or identical sugars, each of which is 
interlinked by glycosidic linkages. Since differences are possible for sugar type, nature, ring 
form, substitution and sequence within the repeat units, a large amount of variation is 
observed between LPS expressed by different bacterial strains. The O-polysaccharide is 
much longer than the Core polysaccharide, and it maintains the hydrophilic domain of 
the LPS molecule. Great variation occurs in the composition of the sugars in the O-side 
chain between species and even strains of Gram-negative bacteria. The structures of O-
polysaccharides from numerous bacterial species have been well characterised. 
Common sugars such as pentoses, hexoses, 6-deoxyhexoses, 2-amino-2, deoxyhexoses, 
and uronic acids have been documented in various O-polysaccharide structures. Other 
rarer monosaccharides such as 3,6 dideoxyhexoses, 2-amino-2,6 dideoxyhexoses, and di-
amino sugars have also been found to be present in certain O-polysaccharides. The 
variability observed among various bacterial O-polysaccharides has formed the basis of 
typing schemes such as serotyping. It has been hypothesised that such structural variability 
is an attempt by the bacterium to evade host defences by presenting an O-
polysaccharide not previously recognised by host antibodies or to present O-
polysaccharides resembling host structures recognised as self by the host immune system. 
The latter strategy is termed molecular mimicry, but may, however, contribute to the 
pathogenic potential of some bacteria. The tertiary structures of O-polysaccharides is 
important in interactions with antibodies, porins, and LPS-binding protein . They also play a 
role in activating complement by the alternate pathway and as receptors for 
bacteriophages. Particular sugars in the structure, especially the terminal ones, confer 
immunological specificity of the O-antigen, in addition to "smoothness" (colony 
morphology) of the strain (S strain). Loss of the O-specific region by mutation results in the 
strain becoming a "rough" (colony morphology) or R strain. Loss of the O-antigen results in 
loss of virulence suggesting that this portion is important during a host-parasite interaction. 
It is known that R-LPS strains are more susceptible to phagocytosis and killing by 
bactericidal serum factors in vivo. Only smooth strains, protected by their O- 
polysaccharide chains, can survive in the host.  
 
1.3. Extracellular and Capsular polysaccharides  
 
Exopolysaccharides (EPSs) are long-chain polysaccharides that are secreted mainly by 
bacteria and microalgae into their surroundings during growth and that are not 
permanently attached to the surface of the microbial cell. A second group of 
polysaccharides that are structurally similar but that are permanently attached to the cell 
surface are classified as capsular polysaccharides. 
 
EPSs may be present in both Gram-negative and gram-positive bacteria. They can be 
released from the cell into the environment as a slime or remain attached to the cell 
surface to form a capsule. In their natural environment, they are thought to play a role in 
the protection of the microbial cell against desiccation, phagocytosis and phage attack, 
antibiotics or toxic compounds (e.g. toxic metal ions, sulphur dioxide, ethanol), predation 
by protozoans, osmotic stress, adhesion to solid surfaces and biofilm formation, and also in 
cellular recognition (via binding to a lectin). The polysaccharide capsule often constitutes 
the outermost layer of the cell; as such, it may mediate direct interactions between the 
bacterium and its immediate environment. Capsular polysaccharides are linked to the cell 
surface of the bacterium via covalent attachments to either phospholipid or lipid-A 
molecules. In contrast, extracellular polysaccharides molecules appear to be released 
onto the cell surface with no visible means of attachment and are often sloughed off to 
form slime. The release of polysaccharide from the cell surface must be used with caution 
as a criterion for differentiating between capsules and EPSs. Capsular polysaccharides 
may themselves be released into the growth medium as a consequence of the stability of 
the phosphodiester linkage between the polysaccharide and the phospholipids 
membrane anchor. They can be homo- or hetero-polymers and may be substituted by 
both organic and inorganic molecules. Any two monosaccharides may be joined in a 
number of configurations as a consequence of the multiple hydroxyl groups within each 
monosaccharide unit that may be involved in the formation of a glycosidic bond. As a 
result, capsular polysaccharides are an incredibly diverse range of molecules that may 
differ not only by monosaccharides units but also in how these units are joined together. 
The introduction of branches into the polysaccharide chain and substitution of both 
organic and inorganic molecules yield additional structural complexity.   
 
 
1.3.1. Production and synthesis 
 
Extracellular and capsular polysaccharides are produced by a wide range of bacteria, 
including important pathogens of humans, livestock, and plants. These polymers are major 
surface antigens and serve a variety of roles in virulence, depending on the biology of the 
producing organism. In addition to their importance in disease, some EPSs also have 
industrial applications as gelling and emulsifying agents. Some EPS are synthesised 
throughout bacterial growth, whereas others are only produced during late logarithmic or 
stationary phase. Production of most of these polymers is favoured by nutrient imbalance 
such as high C:N ratios, and often by sub-optimal incubation temperatures. High aeration 
may also be needed. Unfortunately, these same growth conditions favour synthesis of 
storage polymers such as glycogen and polyb- hydroxybutyric acid (PHB). In K. aerogenes 
grown under high carbon : nitrogen ratios, EPS and glycogen competed for substrate(2). It 
is fortuitous that X. campestris, which gives conversion rates of carbon substrate to 
polysaccharide of up to 70%, lacks such intracellular products. Gellan yields are lower, as 
S. elodea makes considerable quantities of PHB in addition to polysaccharide. Synthesis of 
all these EPSs is an intracellular process utilising nucleoside diphosphate sugars and 
considerable progress has been made in recent years in determining the biosynthetic and 
genetic mechanisms involved. These usually involve a cassette of genes, the products of 
which are responsible for the addition of individual sugars to isoprenoid lipid acceptors 
and of any acylation. Typically, a gene sequence of the order of 1217 kb may be 
required depending on the complexity of the polysaccharide. Interestingly, in the case of 
xanthan, additional acylation genes were discovered. The repeating units are polymerised 
on the carrier lipids then excreted into the extracellular environment(3). 
 
 
 
1.4.         Subject of the study 
 
In summary, bacterial polysaccharides are a diverse range of biologically important 
molecules. They play pivotal roles in mediating a number of biological processes and are 
accepted products for modern biotechnology. Many sectors of industry are showing a 
growing interest for microbial polysaccharides: the topic of this research deals with the 
structure and the structure/function analysis of microbial polysaccharides with 
biotechnological interest. The following strains have been selected: 
 
- Escherichia coli O5:K4:H4 
- Agrobacterium tumefaciens A1, F/1, TT9, and TT111 
- Lactobacillus crispatus B6    
 
E. coli strain O5:K4:H4 produces an extracellular polysaccharide that warrants special 
notice because it bears close structural relationship to chondroitin found in human 
cartilage, whereas EPSs from Lactobacillus crispatus have received increasing interest from 
pharmaceutical companies due to their potential use as probiotics and microbicides. 
Strains belonging to the phytopathogenic Agrobacterium tumefaciens have been critical 
for the development of plant bioengineering and are object of intense structural studies in 
order to further understand their biological properties. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 2 
 
Escherichia coli 
 
 
Escherichia coli (named after Theodor Escherich, 1857-1911) is a Gram-negative, rod-
shaped bacterium. It is the head of the large bacterial family (Enterobacteriaceae). The 
enteric bacteria are facultative anaerobic bacteria that live in the intestinal tracts of 
animals in health and disease, and they are among the most important bacteria 
medically. A number of genera within the family are human intestinal pathogens (e.g. 
Salmonella, Shigella, Yersinia). Several others are normal colonists of the human 
gastrointestinal tract (GI) (e.g. Escherichia, Enterobacter, Klebsiella). E. coli isolates 
produce two serotype-specific surface polysaccharides: the lipopolysaccharides O 
antigen and the capsular polysaccharide K antigen. 
 
 
 
2.1. E. coli serotypes 
 
Different strains of  E. coli are defined serologically by distinctive antigens: over 700 
antigenic types (serotypes) are recognized based on O, K, and H antigens. Serotyping is 
still important in distinguishing the small number of strains that actually cause disease. 
Following the extensive investigations in the 1930's on the serological characterization of 
the Salmonella group of organisms, F. Kauffmann turned his attention to the E. coli group. 
He based the serotyping scheme on three types of antigen:  
a. The somatic (O) antigen, derived from the cell wall. These are composed of 
lipopolysaccharide complexes, which are part of the cell wall structure of the E. coli. It is 
the immunogenicity of the polysaccharide repeating units which gives the O antigens their 
specificity. A number of the O antigens either strongly cross-react serologically or are even 
identical both chemically and serologically to somatic antigens of other organisms. 
b. The capsular (K) antigen, derived from polysaccharide capsules secreted by the 
organism. These are mainly acidic polysaccharide and were initially  subdivided into three 
types depending on their heat-sensitivity. The thermostability or thermolability properties 
reflect differences in the means by which the capsule is linked to the cell surface. Despite 
extensive studies describing the repeating unit structure of K antigens, the precise linkages 
of capsules to the cell surface are still not fully resolved in all E. coli groups(4).  
c. The flagellar (H) antigen, derived from flagella and only found on motile strains. Their 
antigenic diversity is based on the different types of flagellin present as part of the flagellar 
structure. Many E. coli on primary isolation are either only sluggishly motile or non-motile. 
However, many strains on passage through a semisolid agar attain full motility. Only such 
strains are suitable for H typing. Those strains not developing motility are designated non-
motile (NM) or H-. Initially Kauffmann described 25 O, 55 K and 20 H antigens. As new 
antigens are being described new numbers are being added to the scheme(5).  
 
 
 
 
2.2. Biosynthesis and function of bacterial capsular polysaccharides  
 
Polysaccharide capsules are structures found on the cell surface of a broad range of 
bacteria. Pathogenic bacteria are notorious for their ability to surmount host defences by 
producing a wide gamut of virulence factors that enhance microbial infectivity. One such 
factor is the capsule, an extracellular polymer coating surrounding the microbial cell(6). 
Pathogens that lose the ability to produce a capsule are often attenuated or non virulent. 
The majority of described capsules are composed of long anionic polysaccharide chains, 
but neutral polysaccharides as well as proteinaceous components are also observed in 
some cases. The introduction of branches into the polysaccharide chain yield additional 
structural complexity. Biosynthesis and assembly of capsular polysaccharides is a complex 
process: in Gram-negative bacteria, it is proposed that biosynthesis and translocation of 
capsular polysaccharides to the cell surface are temporally and spatially coupled by 
multiprotein complexes that span the cell envelope. Activated precursors (nucleotide 
monophospho and diphospho sugars) in the cytoplasm are assembled into the nascent 
polysaccharide (Mr > 100.000 Da) by enzymes associated with the inner membrane. A 
dedicated translocation pathway moves nascent polymer through the periplasm and 
across the outer membrane to the cell surface. Current data suggest that capsule 
biosynthesis and assembly machinery form a transmembrane complex, but how this 
complex cross the peptidoglycan layer without compromising cell wall integrity and how 
its activity is coordinated with others involved in membrane biogenesis during cell growth 
and division is still unknown(4). E. coli capsules are surface-enveloping structures comprising 
high-molecular-weight polysaccharides that are firmly attached to the cell. An 
understanding of the synthesis and expression of E. coli K-antigens has allowed their 
classification into four different groups. These groups include two fundamentally different 
polymerisation pathways and both are widespread among different bacteria(13). E. coli 
group 1 and 4 capsules share a common assembly system, and this is fundamentally 
different from the one used for group 2 and 3 capsules. In this classification, the E. coli 
strain O5:K4:H4 belongs to the group 2 capsules(4). 
A number of  possible functions have been suggested for polysaccharide capsules, such 
as prevention of desiccation(7), adherence of  bacteria to surfaces and to each other to 
facilitate the formation of a biofilm and the colonization of various ecological niches(8), 
resistance to specific and non-specific host immunity: during invasive bacterial infections, 
interactions between the capsular polysaccharide and the hosts immune system can 
decide the outcome of the infection. In the absence of specific antibody, the presence of 
a capsule is thought to confer resistance to non-specific host defence mechanisms by 
providing a permeability barrier to complement components, thereby masking underlying 
cell surface structures that would otherwise be potent activators of the alternative 
complement pathway(9). The net negative charge conveyed on the cell surface by the 
polysaccharide capsule may also serve to confer resistance(10,11,12): the more highly 
charged the capsular polysaccharide is, the greater is the degree of resistance to 
phagocytosis. 
 
 
 
2.3.  Cell surface polysaccharides in Escherichia coli 
 
The pathogenicity of Escherichia coli is, to a large extent, determined by capsular 
polysaccharides.The cell surface of E. coli is a complex array of proteins and 
glycoconjugates. The capsular polysaccharides (CPSs) and the O-polysaccharides of the 
lipopolysaccharide (LPS) molecules are the major surface polysaccharides expressed at 
37°C. These polymers are serotype specific and give rise to the K- and O- antigens, 
respectively. Variations in sugar composition, linkage specificity, as well as substitution with 
non-carbohydrate residues result in 167 different O-serogroups and more than 80 
polysaccharide K-antigens in E. coli. The primary structures of many of these antigens have 
been elucidated. The O- and K- antigens provide recognized virulence determinants. 
Generally, the O-antigens are important for resistance to complement-mediated serum 
killing, whereas the capsular K-antigens are responsible for resistance against 
phagocytosis.  
 
 
 
2.4.  Sulphated Glycosaminoglycans (GAGs) 
 
Both vertebrates and certain microbes produce glycosaminoglycans (GAGs), long linear 
polysaccharides consisting of repeating disaccharide units containing a derivative of an 
amino sugar (either glucosamine or galactosamine). The physiologically most important 
GAGs are hyaluronic acid, dermatan sulphate, chondroitin sulphate, heparin, heparin 
sulphate and keratin sulphate. Hyaluronan [β(1→4)GlcA-β(1→3)GlcNAc], chondroitin 
[β(1→4)GlcA-β(1→3)GalNAc], and heparan sulfate/heparin [α(1→4)GlcA-β(1→4)GlcNAc] 
contain an uronic acid as the other component of the disaccharide repeat, while keratan 
[β(1→4)GlcNAc-β(1→3)Gal]contains a galactose. GAGs are located primarily on the 
surface of cells or in the extracellular matrix, where they play structural, recognition and 
adhesion roles. In the form of proteoglycans, they comprise the ground substance in the 
extracellular matrix of connective tissue. By virtue of their physical characteristics, namely 
a high negative charge density and a multitude of polar hydroxyl groups, GAGs help 
hydrate and expand tissues(19-22). Along with the high viscosity that they impart to the 
solution comes low compressibility, which makes these molecules ideal for a lubricating 
fluid in the joints. Charged groups such as carboxyl and sulphate are neutralized by 
cations which, in turn, attract and retain large quantities of water by osmotic forces. These 
forces equilibrate with the tensile forces on the intervertebral discs. The biochemical 
composition thus offers the central matrix the unique capacity to create a hydraulic 
space of fixed volume and alterable dimension(14). Certain pathogenic bacteria produce 
extracellular capsules composed of GAGs or GAGs-like polymers that enhance the 
microbes ability to infect or to colonize the host.  
 
 
 
 
2.5.  Chondroitin Sulphate 
 
Glycosaminoglycans of articular cartilage consist mainly of chondroitin sulphate (about 
80% of the total amount of GAGs). This molecule consists of a repeating disaccharide unit 
built up of glucuronic acid (GlcA) and N-acetylgalactosamine (GalNAc). GalNac residues 
are usually sulphated in position 4 and/or 6. The significance of the position of sulphate 
group is unknown. Biological variability in the sulphation position exists: maturation and 
ageing causes a shift from 4 to 6 sulphation and a high degree of 4,6 disulphation at the 
GAG terminal residues, which is much decreased in degenerated cartilage(14). Cartilage is 
a highly specialized, dense connective tissue found between the surfaces of movable 
articular joints whose main function is to bear stresses during joint motion. It possesses high 
stiffness, strength, resiliency and shock absorption. Although cartilage is composed of 
many different molecules, GAGs are the major determinants of the tissues ability to resist 
compressive loading. Chondroitin sulphate is found in humans in cartilage, bone, cornea, 
skin and the arterial wall. This type of chondroitin sulphate is sometimes referred to as 
chondroitin sulphate A. The amino group of galactosamines in the basic unit of chondroitin 
sulphate A is acetylated, yielding N-acetylgalactosamine (GalNAc); there is a sulphate 
group esterified to the 4-position in GalNAc. Chondroitin sulphate A is also sometimes 
called chondroitin 4-sulphate and Its molecular weight ranges from 5.000 to 50.000 Da. 
Chondroitin sulphate C, primarily found in fish and shark cartilage, but also in humans, is 
also made up of linear repeating units of GalNAc and GlcA, but the sulphate group is 
esterified to the 6-position in GalNAc. Chondroitin sulphate C is sometimes called 
chondroitin 6-sulphate. Chondroitin sulphate B is also known as dermatan sulphate. It is 
abundant in skin and it is also found in heart valves, tendons and arterial walls. Dermatan 
sulphate is made up of linear repeating units containing D-galactosamine and either L-
iduronic acid or D-glucuronic acid. Its molecular weight ranges from 15.000 to 40.000 Da. 
Due to the presence of sulphate groups in different amounts and positions (2 and 3 of 
GlcA, 4 and 6 of GalNAc residues), chondroitin sulphate represents a heterogeneous 
family of polysaccharides(16). Such a large heterogeneity makes necessary an accurate 
evaluation of their structures and properties, charge density and position of sulphate 
groups, which is of paramount importance mainly for pharmacological applications. 
Furthermore, chondroitin is an expensive material, so experts have been concerned about 
the quality and quantity of the ingredient in the supplements. The source of chondroitin 
sulphate used in nutritional supplements includes the cartilaginous rings of bovine trachea 
and pork by-products (ears and snout). Shark cartilage and whale septum cartilage have 
also been used. Because chondroitin usually comes from cow cartilage, an additional 
concern has been whether the products may be contaminated with bovine spongiform 
encephalitis, the causative agent (a prion) of Mad Cow Disease. The risk, however, 
seems to be minuscule since the prion is known to exist only in very low levels in cartilage, 
while it is most abundant in nervous and glandular tissues. Unfortunately, theres no simple 
way to test for BSE prion contamination in supplements, so pharmaceutical companies are 
looking forward to safer products. Chondroitin sulphate supplements are usually isomeric 
mixtures of chondroitin sulphate A (chondroitin 4-sulphate) and chondroitin sulphate C 
(chondroitin 6-sulphate)(15). These preparations are widely used as food supplements to 
slow the progression of osteoarthritis - the deterioration of cartilage between joint bones - 
and to reduce the associated pain. Chondroitin supplements are also employed as 
chondroprotective, with application in the therapy of tibiofibular osteoarthritis of the 
knee(17), finger joints and hip, and may possibly have beneficial effects on cartilage of all 
joints, including the intervertebral disc(14).          
  
 
 
2.6.  Escherichia coli O5:K4:H4 
 
Three E. coli capsular types, K1, K4 and K5, make polymers composed of GAG-like 
polymers. The K1 polysaccharide is a poly(2→8)-α-N-acetylneuraminic acid, the K5 
polysaccharide [with the repeating unit -4)-β-D-GlcA-(1→4)-α-D-GlcNAc-(1-] has a 
structure alike to N-acetylheparosan, the precursory polymer of heparin and heparin 
sulphate. The K4 polysaccharide synthesized by  E. coli strain O5:K4:H4 has a non sulphated 
chondroitin backbone decorated  with fructose side branches on the C3 position of the 
GlcA residues. Biochemical analysis demonstrated that a single GalNAc residue is added 
to a non reducing terminal GlcA residue of a chondroitin-derived oligosaccharide 
acceptor. It appears that the fructose branch is added to the K4 polymer chain after the 
GAG repeat is formed because defructosylated K4 oligosaccharide but not the intact 
native K4 oligosaccharide served as an acceptor. The fructose branch makes the 
chondroitin polymer more antigenic. At this time, an E. coli capsular type without fructose 
moiety has not been reported(18). In this context, it is of great interest to have a procedure 
that could rapidly defructosylate the native K4 and purify it from the toxic LPS so to obtain 
a suitable product that could be further sulphated in the desired positions. In order to set 
up a purification protocol suitable for an industrial scale up process, different methods 
have been tested to develop a viable commercial process economically advantageous 
and ecologically compatible. 
 
 
 
 
 
2.7. Precipitation of acidic polysaccharides with cetyltrimethylammonium 
bromide  
 
 
Extraction with a cetyltrimethylammonium bromide solution (Cetavlon) is a procedure 
suitable for lipopolysaccharide preparation. This method is typically used to purify LPS from 
residual nucleic acids after phenol/water extraction. Removal of nucleic acids is achieved 
by their preferential precipitation with a cationic detergent such as Cetavlon. Nucleic 
acids are more strongly acidic than the phosphoric acid ester-containing LPS and form a 
water-insoluble salt with Cetavlon while the LPS complex remains in solution. Such 
procedure is effective to separate acidic polysaccharides from LPS as well. Separation of 
the acidic polysaccharides and nucleic acids is based on the fact that the Cetavlon 
complexes of the polysaccharides are soluble at different concentration in a  sodium 
chloride (NaCl) solution, compared with the Cetavlon-nucleic acids complexes. Srivastava 
and co-workers(23) used a similar method for the isolation and purification of acidic 
polysaccharides from Serratia marcescens. Orskov prepared acidic polysaccharide 
antigens from E. coli capsules by application of this procedure(24).  Rodriguez et al. took 
advantage of this methodology as well to precipitate the K4 capsular polysaccharide 
from the liquid cultures. Following this pipeline, a modified procedure similar to those cited 
above has been developed. As reported from Rodriguez, the K4 capsular polysaccharide 
was precipitated from the liquid cultures by addition of Cetavlon, then it was extracted  
from the precipitate with calcium chloride and purified by several cycles of precipitation 
with ethanol. Contaminating proteins were removed by repeated extraction with cold 
phenol. The process described below presents some differences. The first innovation lies in 
the fact that the  precipitation with Cetavlon was performed on the culture filtrate after 
ultrafiltration and diafiltration, so that there was no need of an additional purification with 
phenol. Besides, the entire purification protocol shows some improvements in the modus 
operandi.     
 
 
2.7.1. Experimental procedure 
 
Ultrafiltrated, protein free and lyophilised fermentation broth containing extracellular K4 
polysaccharide and LPS was subjected to precipitation with Cetavlon.  The content of 
uronic acid in the sample was about 45% as determined using the uronic acid assay. 300 
mg were dissolved in 15 mL of deionised water,  35 mL from a 3% Cetavlon solution were 
added. The sample was allowed to precipitate for 4 hours at room temperature, then it 
was centrifuged (7000 rpm, 30 min, 25°C). The precipitate was dissolved in the minimum 
amount of 1.5 M NaCl and purified by three cycles of precipitation with 30 mL of ethanol. 
In each subsequent cycle the concentration of NaCl solution was reduced to a half (i.e.  
0.75 M, 0.3 M, H2O milliQ). After the last cycle the precipitate was dissolved in deionised 
water and lyophilised. The supernatants were collected together and dialysed against 1M 
NaCl (membrane cut off 12.000-14.000 Da). Both supernatant and precipitate (yield 112 
mg)  were screened by SDS-PAGE 12% and analysed by GC-MS and NMR (Fig. 2.1 - 2.4).  
 
Fig.2.1.  GC-MS chromatogram of  K4 capsular before Cetavlon extraction.  
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 Fig.2.2.  GC-MS chromatogram of  K4 capsular after Cetavlon extraction.  
 
 
 
Fig.2.3.  1H NMR spectrum of  K4 capsular before Cetavlon extraction.  
 
Fig.2.4.  1H NMR spectrum of  K4 capsular after Cetavlon extraction.  
 
 
2.7.2. Results and discussion 
 
Characterization of the precipitate after extraction with Cetavlon showed it to be 
composed of K4 polysaccharide (the yield obtained was approximately 100%) without the 
endotoxin LPS. The structure was investigated by composition, methylation and by 1D and 
2D nuclear magnetic resonance spectroscopy. The polysaccharide was determined to be 
composed of repeating disaccharide subunit of D-glucuronic acid (GlcA) (β 1→3) and N-
acetyl-D-galactosamine (GalNAc) (β 1→4) to which β-fructofuranose units are linked to C-
3 of D-glucuronic acid residues. Such procedure is useful to obtain a product which can 
be easily defructosylated under acid conditions to produce a polysaccharide having the 
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structure of nonsulfated chondroitin. Traces of Cetavlon were always present in the sample 
and all attempts to completely remove it failed. As a consequence, this product was used 
to further improve other purification processes, but it was not suitable to be proposed as 
an active pharmaceutical ingredient.    
 
 
 
 
 
 
2.8. Solid Phase Extraction 
 
 
2.8.1. Charcoal as adsorbent for Solid Phase Extraction 
 
Solid phase extraction (SPE) is an extraction method that uses a solid phase and a liquid 
phase to isolate one, or one type of analyte, from a solution. Commercial SPE cartridges 
have 1-10 mL capacities and are made of activated charcoal. Activated carbon is a 
crude form of graphite, it differs from graphite by having a random imperfect structure 
which is highly porous: the size of the pores varies from micropores (2 nm), to mesopores (2-
50 nm), to macropores (greater than 50 nm). The graphite structure gives the carbon its 
extraordinarily large surface area (300-2000 m2/g)(25) which allows the carbon to adsorb a 
wide range of compounds(26). Activated charcoal is manufactured from a variety of 
sources containing a high carbon content such as coal, wood, lignite and coconut shells. 
The raw material has a very large influence on the characteristic and performance of 
activated carbon. The process includes first carbonising the raw material at low 
temperatures, and then activating the carbon in a high temperature steam process. There 
are two forms of activated carbon used as adsorbent: granular activated carbon (GAC) 
and powder activated carbon (PAC). The type chosen is determined by the desired 
physical and chemical properties. The most important physical parameters are specific 
surface area, pore size distribution, specific adsorption capacity and particle size. The most 
important chemical properties are ash composition and pH. The specific mode of action is 
extremely complex, since activated carbon has both chemical and physical effects on 
substances. Activity can be separated into (1) adsorption; (2) mechanical filtration; (3) ion 
exchange. The most studied of these properties is adsorption, the process that occurs 
when components of a liquid attaches to a solid surface. This can be either physical or 
chemical, and frequently involves both. Physical adsorption involves the attraction by 
electrical charge differences between the adsorbent and the adsorbate. Chemical 
adsorption is the product of a reaction between the adsorbent and the adsorbate. 
Adsorption capacity depends on many factors: physical and chemical characteristics of 
adsorbent and adsorbate, concentration of the adsorbate in liquid solution, 
characteristics of the liquid phase (pH, temperature). Mechanical filtration involves the 
physical separation of suspended solids from a liquid passing through carbon arrayed as a 
porous media in a column. The effectiveness of filtration depends on particle size and 
hardness(27). While a smaller particle size results in a clearer liquid, it also slows the speed of 
processing. As for ion exchange, coal is a natural ion exchanger(28), and chemical 
activation can enhance ion exchange. Carbon surfaces have both negative or positive 
charges to attract free ions in solution. Treatment of carbon with a base increases the 
capacity of carbon to exchange anions, while acidulation of the surface makes carbon a 
powerful cation exchanger(29). Activated charcoal has long been used for the preparative 
chromatographic fractionation of mixtures of oligosaccharides obtained by partial acid 
hydrolysis of polysaccharides(30). GAC adsorption has been used successfully for the 
advanced treatment of industrial wastewater, to adsorb soluble organics and inorganic 
compounds such as nitrogen, sulphides and heavy metals(31). Applications of activated 
carbon in the liquid phase include potable water treatment, groundwater treatment, 
decolourisation and chemical and pharmaceutical treatment. After the activated carbon 
has reached exhaustion and all the adsorptive sites are filled, it can be regenerated 
through thermal reactivation, by heating it at a temperature of 820 to 930 °C. Recovery of 
the carbon ranges from 90 to 95%. Alternatively, regeneration can take place by steam 
stripping (volatile constituents are removed with the steam passed through a bed of 
charcoal granules), solvent regeneration or wet air oxidation. 
 
 
 
2.8.2. Carbograph solid phase extraction 
 
 
Carbograph solid phase extraction packing is a homogenous graphitised carbon black 
with a surface area of 100m2/g and a particle size of 38-125 µm. A graphitised carbon is a 
graphitic carbon with more or less perfect three-dimensional hexagonal crystalline order 
prepared from non-graphitic carbon by graphitization heat treatment. The primary 
retention mechanism is reversed-phase, but under certain conditions cationic areas of the 
carbon surface will act as anion exchange sites. This mixed-mode characteristic allows the 
separation of acidic compounds from basic and neutral compounds(32).  
 
 
 
2.8.3.  Experimental Section 
 
A method to purify K4 from LPS using solid-phase extraction was developed. SPE was 
performed using Carbograph cartridges, Activated Carbon powder and Activated 
Carbon granular. For this purpose, K4 sample (containing both exopolysaccharide and 
lipopolysaccharide) was hydrolysed (acetic acid 1%, 100°C 2h, solution at 25 mg/mL). Lipid 
A was removed by centrifugation, while the recovered supernatant was dialysed for 24 h 
against deionised water to remove fructose. GC-MS and NMR analysis of the resulting 
material showed it to be composed of defructosylated K4 (K4d) and O-Chain. This sample 
was then subjected to SPE. Different solvents such as ethanol, acetone and acetonitrile 
were tested for elution. Acetone and ethanol  eluted compounds incompletely, while 
acetonitrile showed to provide for a more effective elution.  
 
 
 
Materials 
Carbograph cartridges (150 mg, 0.5 mL) were from Alltech Associates Inc., Activated 
Carbon type Norit CN1 from wood and Activated Carbon granular Norit type Darco from 
lignite were from Fluka. Dialysis tubes having a cut-off range of 12-14000 Da were from 
Spectrum Labs. Glass columns were from Microglass s.r.l.. 
 
CARBOGRAPH 
Carbograph cartridge was washed with 3 volumes of acetonitrile. Elution was performed 
with five volumes of water , three volumes of  acetonitrile/water 1:3, three volumes of 
acetonitrile/water 1:3 with 0.05% trifluoroacetic acid (TFA). Fractions of 0.5 mL were 
collected and screened using phenol/sulphuric acid and uronic acid assays as described 
elsewhere (Fig. 2.5). Two peaks were collected and subjected to chemical and 
spectroscopic analysis.  
 
 
 
                                                                                                                                 Fig. 2.5.  Phenol/sulphuric acid 
(Abs 490 nm) and uronic acid assays (Abs 520 nm). 
 
 
 
 
 
 
 
 
 
Activated Carbon powder (PCA) and Activated Carbon granular (GCA) 
 
PCA and GCA were used as medium for packing glass columns (20 x 1.8 cm). Batch trials 
on a small amount of carbon were performed as well. In both cases, elution was 
performed as described for Carbograph. Fractions were screened by phenol/sulphuric 
acid, uronic acid assay and SDS-PAGE 12%. In these cases it was not possible to achieve 
an optimal separation of the two substances. In addition, the carbon powder resulted to 
be always present in all the fractions recovered after SPE. 
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2.8.4.  Results and discussion 
 
From all these experiments it was possible to argue that Carbograph cartridges gave the 
best results, providing for a fine and reproducible technique for the purification of K4d from 
O-Chain. Carbon powder resulted to be so fluffy that it couldnt be removed by 
centrifugation. All others attempts to remove it from samples failed. Small amount of 
carbon powder were found in samples also after GCA extraction. Furthermore, in order to 
set up a protocol suitable for an industrial scale up process, it should be considered that 
activated carbon is expensive, thus making regeneration economically desirable but not 
easy to perform on a large scale. Another disadvantage with activated carbon is the high 
emissions of sulphur dioxide generated from the heating process in manufacturing carbon 
from coal, and with the increasing demands for environmental protection it could be 
suitable to look at another viable procedure ecologically compatible.  
 
2.9.  Ion Exchange Chromatography 
 
 
Ion Exchange Chromatography (IEC) is a high resolution technique for separating samples 
according to their charge. It is the most commonly used chromatographic method of 
separation due to its ease of use and scale up capabilities, since large volumes can be 
applied to ion exchange columns. The protocol here described takes advantages of the 
strong anion exchanger Q-Sepharose Fast Flow. Q-Sepharose Fast Flow resin belongs to 
the BioProcess Media family, which are made and supported for industrial scale, especially 
the manufacture of healthcare products. The ion exchange group is a quaternary amine 
which remains charged and maintains constantly high capacities over the entire working 
range (pH 2-12). With its elevated physical and chemical stability and its high 
reproducibility it is ideal for all stages of an operation, from process development through 
scale-up and into production.  
 
 
 
Materials 
 
Ion-exchange resin Q-Sepharose Fast Flow was from GE Healthcare. Dialysis tubes having 
a cut-off of 12-14.000 Da were from Spectrum Labs. Glass columns were from Microglass 
s.r.l.. 
  
 
Purification of K4 polysaccharide 
 
The broth culture concentrated by ultrafiltration and after enzymatic deproteinization was 
dialysed, lyophilised and analysed by  uronic acid assay, GC-MS and NMR. The content of 
K4 polysaccharide was about 53%. The polysaccharide sample (1.1 g) was hydrolysed with 
1% acetic acid at 100°C for 2 h (solution at 25 mg/mL) and then centrifuged to remove the 
precipitate (lipid A, yield 253 mg). The supernatant was dialysed against deionised water 
to remove fructose, then it was lyophilised again (yield  800 mg). The subsequent 
purification was carried out by passing it through a column (2.4 x 34 cm) packed with Q-
Sepharose FF resin equilibrated with 10 mM NaCl. The column was then washed with three 
volumes of 100 mM and 1 M NaCl (flow rate 200 mL/h). Fractions of 12 mL were collected 
and screened by phenol/sulphuric acid and uronic acid assays. Two peaks (A and B) were 
obtained by the phenol test. Only peak B gave a positive match to uronic acid assay. On 
the basis of the chromatogram reported in Fig. 2.6., peaks A and B were pooled, dialysed 
and freeze-dried. Approximately 390 mg of the purified K4 and 380 mg of the O-Chain 
were recovered. Characteristics of the two samples obtained at the end of purification  
were analysed according to chemical and spectroscopic analysis (Fig. 2.7 and Fig. 2.8).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.6. Uronic acid (Abs 520nm) and phenol/sulphuric acid assay (Abs 490nm). 
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Fig. 2.7. 1H NMR spectrum of O-Chain. 
 
 
 
 
 
 
Fig. 2.8. 1H NMR spectrum of purified defructosylated K4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                         2.9.1.  Results and discussion 
 
 
The spectra of the defructosylated K4 and the antigenic O-polysaccharide component 
were similar to the spectra reported in literature. Their structures were investigated by 
composition, methylation and by 1D and 2D nuclear magnetic resonance spectroscopy. 
The purified K4 polysaccharide resulted to be composed of equimolar quantities of 
glucuronic acid and N-acetylgalactosamine in a linear chain. Both NMR spectra and GC-
MS chromatogram showed the absence of fructose previously bonded in a lateral chain 
with carbon 3 of glucuronic acid. The K4 polysaccharide produced and purified with the 
procedure described above has the structure reported below: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The O-Chain was determined to be composed of repeating tetrasaccharide units 
containing D-ribose (Rib), D-N-acetylgalactosamine (GalNAc), D-galactose (Gal), 3-N-
Acetyl-6-deoxy-D-glucose (Quin3NAc) and having the following structure: →4)β-D-
Quin3NAc(1→3)β-D-Ribf(1→4)β-D-Gal(1→3)α-D-GalNAc(1→ . 
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The process described above for the isolation and purification of the bacterial K4 antigen 
allows this polymer to be obtained with very high purity (100%) and with higher yields than 
when using other known procedures. The non sulphated K4 polysaccharide is 
defructosylated and it is the suitable substrate for successive reactions: it can be O-
sulphated in position 4 and/or 6 of the galactosamine to obtain chondroitin sulphate. The 
possibility of producing the extracellular K4 by means of a fermentation on a large scale 
and the subsequent purification process supplies a polysaccharide precursor of 
chondroitin sulphate. Such polymer can be transformed, by means of economically 
advantageous industrial processes of selective sulphation, into chondroitin sulphate.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3 
 
 
Agrobacterium tumefaciens 
   
 
Agrobacterium tumefaciens is a Gram negative, non sporing, rod-shaped soil plant 
pathogenic bacterium, closely related to Rhizobium. Plant transformation mediated by A. 
tumefaciens has become the most used method for the introduction of foreign genes into 
plant cells and the subsequent regeneration of transgenic plants. The first evidence 
indicating this bacterium as the causative agent of the crown gall, a disease affecting a 
wide range of plants, goes back to one hundred years ago: in 1907, Erwin F. Smith and C. 
O. Townsend(33) established that crown gall was caused by a bacterium which they 
named Bacterium tumefaciens, later changed to Agrobacterium tumefaciens by Conn in 
1942. In the same year, White and Braun showed that although A. tumefaciens was 
necessary for the induction of crown gall, once the gall was initiated, the bacteria could 
be eliminated without affecting gall growth. The next noteworthy development was the 
discovery of opines in the late 1960s by Morel and his colleagues in France. Opines are 
unusual compounds resulted from condensation between amino acids and sugars, which 
are produced and excreted by the crown gall cells. Examples are octopine, nopaline, 
agropine and agrocinopine, which are not synthesized by normal plant tissues. The kind of 
opine synthesized depends not on the plant but on the inciting bacterium which can 
catabolize the synthesized opines and use them as a source of energy, carbon and 
nitrogen. Strain of  A. tumefaciens are frequently classified according to opines 
synthesized. In 1975 it was showed that genes for pathogenicity are located on a large 
plasmid called the tumour-inducing (Ti) plasmid. The bacterium has the particular ability to 
transfer a  small DNA segment (called transfer DNA or T-DNA) of the Ti plasmid into the 
nucleus of infected plant cells, where it is subsequently stable integrated into the host 
genome and transcribed(34,35). As expected, the oncogenic genes encoding for enzymes 
involved in the synthesis of auxins and cytokinins (responsible for the tumour formation) 
and the genes encoding for the synthesis of opines are located within the T-DNA. Outside 
the T-DNA are located the genes for the opine catabolism and the genes involved in the 
process of T-DNA transfer from the bacterium to the plant cell(36,37). As a result of T-DNA 
transfer, the plant is directed to synthesize compounds which it cant utilize: only the 
inciting bacterium benefits from such substances. Although A. tumefaciens naturally 
infects only dicotyledonous plants and many economically important plants (including the 
cereals, nuts, ornamentals, vines and canes), during the last decade reproducible and 
efficient methodologies were established on monocotyledonous plants such as rice(38,39), 
banana(40), corn(41), wheat(42) and sugarcane(43,44).   
 
 
3.1.  Disease Cycle 
A. tumefaciens can survive in soil as a saprophyte for short periods before it invades a host 
plant through a wound. It is found commonly in the rhizosphere (the region on and around 
root surfaces), where it seems to survive by using nutrients that leak from the root tissue. The 
motile cells of A. tumefaciens are attracted to wound sites in response to the release of 
sugars and other common root components(Fig.3.1.).  
 
 
 
 
 
 
 
 
 
Fig. 3.1. Agrobacterium attaches to plant cell. 
 
 
Once within the plant, the bacterium induces formation of a gall by transferring its T-DNA 
into the cell of the plant, where it becomes integrated into the plants genome (Fig.3.2).  
 
 
 
 
 
 
 
 
Fig. 3.2. T-DNA transfer. 
 
Genes on this tumour-inducing (Ti) plasmid cause the plant cell to divide repeatedly, thus 
forming the tumour. Crown galls typically form on the root crown of the plant near the 
soil line but also can form on roots or on aboveground stems and twigs. The galls are 
initially small and usually white or tan, more or less round, and spongy in texture. As the 
galls enlarge, the outer tissue gradually darkens to brown and becomes convoluted and 
rough, and the inner tissue becomes hard. The bacteria live and multiply in the intercellular 
spaces of the gall and are released back into the soil when the gall eventually 
deteriorates. 
3.2.  Agrobacterium tumefaciens T-DNA transfer process 
 
The process of gene transfer from A. tumefaciens to plant cells implies several steps: (1) 
bacterial colonisation, (2) induction of bacterial virulence system, (3) generation of T-DNA 
transfer complex, (4) T-DNA transfer and (5) integration of T-DNA into plant genome and its 
expression(45). Virulent bacteria recognize wound phenolic compounds such as 
acetosyringone as a signal which attracts the motile cells of A. tumefaciens to wound sites. 
Thus, one of the functions of the Ti plasmid is to code for specific receptor that are inserted 
in the bacterial membrane and enable the bacterium to recognise wound sites. 
Acetosyringone plays a further role in the infection process, because at higher 
concentrations it activates the virulence genes on the Ti plasmid. The vir genes products, 
among other function, are necessary for the processing and transport of the T-DNA from 
the bacterium to the eukaryotic cell. These genes coordinate the infection process, 
leading to productions of proteins (permeases) that are inserted in the bacterial cell 
membrane for the opines uptake and causing the production of an endonuclease (a 
restriction enzyme) that excises the T-DNA. The bacterium releases the excised T-DNA that 
enters the plant cells, where it integrates into the plant chromosomes. The rest of the Ti 
plasmid remains in the bacterium to serve further roles. The mechanism involved in the T-
DNA integration has not been characterized yet, but it is considered that the integration 
occurs by illegitimate recombination(46). When integrated into the plant genome, the 
genes on the T-DNA code for production of cytokinins and opines synthesis. Bacterial 
colonisation is the essential and earliest step in tumour induction(47): Lippincott and 
Lippincott (1977,1980) have shown that the primary event in crown gall tumour induction is 
the attachment of the bacterial cells to the host plant cell wall. The lipopolysaccharides 
(LPSs) and the capsular  polysaccharides (K-antigens) are proposed to play an important 
role in the colonising process(48). Whatley et al. (1976) have demonstrated that the 
Agrobacterium component involved in the microbial-plant adherence is the 
polysaccharide or O-antigen portion of LPS (O-Chain). The lipid A moiety anchors the LPS 
molecule in the outer membrane, while the projecting polysaccharide chains participate 
in the adherence process. On the part of the host cell wall, polygalacturonic acid has 
been implicated in the adherence mechanism because of its excellent ability to inhibit 
tumour induction(49). The knowledge of the structures of the repeating units in bacterial O-
antigens is very important from the biotechnological point of view, since it can lead to the 
understanding, on the molecular level, of the bacterial strain pathogenesis mechanism. 
 
 
 
  
 
3.3. Genetic engineering: plant transformation mediated by Agrobacterium 
tumefaciens 
 
Agrobacterium tumefaciens is more than the causative agent of crown gall disease: it is 
also firstly the natural instance for the introduction of foreign genes in plants allowing its 
genetic manipulation(45). The A. tumefaciens-plant interaction is a process in which a 
prokaryote genetically engineers an eukaryote. The basis of Agrobacterium-mediated 
genetic engineering is that the T-DNA is excised and integrated into the plant genome, so 
any foreign DNA inserted into the T-DNA will also be integrated: replacing the transferred Ti 
genes with resistance genes (to insects or to herbicides) allows to select improved varieties 
which are more productive and resistant to pathogens and diseases. Plant transformation 
mediated by this soil plant pathogen has become the most used method for 
dicotyledonous plant transformation. The transgenic tomatoes do not express the gene for 
polygalacturonase, an enzyme that degrades pectin, leading to softening of the fruit 
tissues. As a result, the tomatoes can be left on the plant for longer to accumulate flavour 
components. Several crops have been engineered to express the insecticidal toxin gene 
of Bacillus thuringiensis(50), so that plants were protected from the ravages of many 
caterpillars. This is highly successful, but it has the potential disadvantage that continuous 
exposure of insects to the toxin will select for the development of toxin resistance. Several 
crops have also been engineered for resistance to herbicides, so that the herbicide can 
be used for weed control without damaging the crop. Consequently, A. tumefaciens has 
been critical for the development of modern plant genetics and agricultural 
biotechnology.  
 
All the bacteria belonging to A. tumefaciens species are phytopathogenic and are object 
of very intensive investigation due to their potential biotechnological use. In order to 
reveal the relationship between the chemical structure of their O-antigenic 
polysaccharides and their involvement during host-pathogen interaction, the following 
strains have been selected and subjected to chemical and spectroscopic analysis: A. 
tumefaciens A1, TT111, F1 and TT9. The first three strains are extensively described in the 
attached articles, the latter one will be discussed in the next chapter.  
 
 
 
 
  
3.4.  Experimental Section 
 
 
 
3.4.1.   Bacterial growth and culture conditions 
 
A. tumefaciens strain DMS 30208 (here referred to as TT9) was grown at 28°C in liquid shake 
culture (200 rpm) in Nutrient Broth (Fluka Nutrient Broth No 4 cod. 03856) for 18 h (early 
stationary phase). The bacterial suspension was centrifuged (3500 × g, 5 min) and 
harvested cells were washed two times sequentially with ethanol, acetone and ethylic 
ether.  
 
 
3.4.2.  Isolation and purification of the LPS 
 
 
Dried cells (yield 0.170 g L-1)were extracted by the phenol/water method. Each phase was 
dialyzed against distilled water and freeze-dried to yield 1.27 g of LPS fraction in the phenol 
phase (23% yield gLPS/gcells) and 183 mg in the water phase (3.3% yield gLPS/gcells). Both 
fractions were screened by discontinuous SDS-PAGE electrophoresis on a 12% gel with a 
Bio-Rad miniprotean gel system. The samples were run at constant voltage (150V) and 
stained by Kittelbergers procedure. The lyophilized product from the phenol phase 
presented a large amount of insoluble product that was removed by centrifugation. The 
supernatant was further purified on Sephacryl HR 400 (Pharmacia, 1.5 x 90 cm, eluent 
NH4HCO3 50 mM, flow 0.5 mL/min). The eluate was monitored with a R.I. refractometer (K-
2310 Knauer) and the collected peaks were again screened on SDS-PAGE leading to 131 
mg of pure LPS fraction (yield 10% from crude phenol extract). 
 
 
 
3.4.3.  Chemical compositional analysis 
 
Monosaccharides as acetylated O-methyl glycoside derivatives and lipids as methyl esters 
were analyzed by GC-MS on an Agilent 5973 instrument, using a SPB-5 capillary column 
(Supelco, 0.25 mm x 30 m, flow rate 0.8 mL/min, He as carrier gas, with the following 
temperature program: 150°C for 5 min, 150→300°C at 5°C/min, 300°C for 5 min). The mass 
spectra were recorded with an ionization energy of 70 eV and an ionizing current of 0.2 
mA. The absolute configuration for Rhamnose and Fucose was determined by analysis of 
the chiral 2-octyl derivatives according to the procedure of Leontein. In order to analyze 
the glycosyl linkage, the permethylated  LPS was recovered in the organic layer of the 
water/chloroform extraction and converted into its partially methylated alditol acetates 
(AAPM), according to the procedure of Sandford. The octyl and AAPM derivatives 
mentioned above were analysed by GC-MS as reported above. 
                       3.4.4.  Isolation of the O-Specific Polysaccharides  
 
 
Purified LPS fraction (7 mg) was dissolved in 1 mL of 1% acetic acid solution and kept at 
100°C  for 2h. After cooling, the solution was centrifuged (7000 rpm, room temperature, 10 
min) and the clear supernatant was freeze-dried. The O-Chain was further purified by HPLC 
on TSK G3000 PWXL (Tosoh Bioscience, 7,8mm ID x 30cm L, eluent H2O, flow 0,7 mL/min), 
previously calibrated with dextran standards. Two fractions (A= 2mg and B= 3 mg) with 
different molecular weight (223.000 Da and 3600 Da, respectively) were obtained in 
approximately 70% yield from LPS. 
 
 
 
 3.4.5.  Determination of Absolute Configuration of Methyl-4-amino-4-deoxy-      
3-O-Methyl-Fucoside 
  
 
Aglycon fraction (∼ 0,5mg) was hydrolyzed with KOH 4M under Argon Atmosphere (120°C 
Overnight) and then neutralized with HCl 4M. After isopropanol was added, the 
precipitate was removed by centrifugation while the supernatant was analyzed by Thin 
Layer Chromatography (TLC) eluting with CHCl3/MeOH/H2O 14:6:1) and by NMR analysis. 
The resulting hexose was p-bromobenzoylated with 2-fold excess of the corresponding 
acyl chloride at room temperature for 5 h with dry pyridine as solvent. Circular Dichroic 
Absorption  (∆ O.D.) was measured in HPLC-grade methanol with a Jasco J-715 instrument. 
The spectrum was elaborated according to the instrument software. The D-configuration 
was established from the positive Cotton effect, which indicated a clockwise 
arrangement of the two p-bromobenzoate chromophores. 
 
 
 
                       3.4.6.   Smith Degradation  
 
 
Purified LPS (16mg) was oxidized with NaIO4 50mM at 4°C for 72 hours, followed by 
reduction (NaBH4, 1 h, Room Temperature), acidification (2M acetic acid), dialysis and 
freeze-drying. The oxidized polymer was then hydrolyzed (0,1% SDS, 50mM AcONa pH 5, 
100°C, 6 h), centrifuged and the supernatant was purified by Sephacryl HR100 (Pharmacia, 
1,5 x 70 cm, eluent NH4HCO3 50mM, flow 0,3mL/min). The eluate was monitored with a R.I. 
refractometer (K-2310 Knauer) and the collected peaks were screened by NMR analysis 
(6% yield from LPS). 
 
 
 
  
3.4.7.  NMR spectroscopy 
 
Spectra of A and B were recorded with a Varian Inova 500 of Consortium INCA (L488/92, 
Cluster 11), operating at 25°C and equipped with a with a z-gradients reverse probe. 
Spectra of all Methyl-4-amino-4-deoxy-3-Methyl-fucopyranoside derivatives were recorded 
with a Bruker DRX 400 spectrometer at 303 K. Chemical shifts of spectra recorded in D2O 
are expressed in δ relative to internal acetone (δ= 2.225 and 31.5 ppm), whereas spectra in 
DMSO are referred to the chemical shifts of the solvent. For the homonuclear experiment, 
solvent saturated DQF-COSY, TOCSY and ROESY spectra, 512 FIDs of 2048 complex data 
points were collected, with 48 scans per FID and using standard manufacturer software. 
The spectral width was set to 10 ppm and the frequency carrier was placed at the residual 
HOD peak and mixing times of 120 and 200 ms were used for TOCSY and ROESY, 
respectively. For the HSQC and HMBC spectra, 256 FIDS of 2048 complex points were 
acquired with 50 scans per FID, the GARP sequence was used for 13C decoupling during 
acquisition. Conversion of the Varian data and processing was performed with Topspin 1.3 
program, the spectra were assigned using the computer program Pronto. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.5.   Results and discussion  
 
Analysis of the GC-MS chromatogram (Fig. 3.1.) of the sample recovered from phenol 
phase extract revealed the presence of four main intense peaks, those found at 7.6 and 
8.2 RT  were identified as Rhamnose and Fucose, respectively, when compared with 
standards. Octyl glycosides and methylation analysis showed the  Rhamnose to be 4-
linked and L configured, whereas Fucose was D configured and 3-linked.  
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C-MS chromatogram of sample recovered from phenol extract. 
 
 
Attribution of the peaks at 41.5 and 42.2 RT was more complicated and it was achieved by 
means of extensive chemical procedures in combination with NMR analysis. Such product 
resulted to be the acetyl derivative of a methyl-4-amino-4-deoxy-3-O-methyl-fucosyde 
linked at N-4 with the new aglycon N-methyl-3,4-dihydroxy-3-methyl-5-oxoproline. This new 
compound, initially suspected to be a contaminant, resulted to be the second antigenic 
moiety produced by A. tumefaciens TT9. In order to prove this hypothesis, LPS fraction was 
subjected to mild acid hydrolysis and it was subsequently purified by HPLC on a gel 
filtration column. The two moieties were obtained in mixture. By means of 2D NMR it was 
possible to identify a first O-Chain (named O-Chain 1) built up of Rhamnose and Fucose.  
Additional data supporting the presence of a second O-Chain were obtained by 
periodate degradation: O-Chain 1 was cleaved selectively, whereas the other compound 
(named O-Chain 2) was recovered unaffected. To further verify these data, the O-Chains 
mixture was hydrolyzed in strong basic conditions (KOH 4M). Under these conditions, O-
Chain 1 was cleaved selectively, while O-Chain 2 was recovered unaltered. Structure 
elucidation was achieved with chemical methods, GC-MS analysis and NMR 
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spectroscopy. 1H and 13C NMR spectra, as well as 2D NMR experiments (DQF-COSY, 
TOCSY, ROESY, HSQC and HMBC) proved to be particularly effective in the 
characterization of the O-Chain 1 and the α/β anomeric mixture of O-Chain 2. The 
structures of the two O-polysaccharides are shown below; the simplest one is a linear 
polysaccharide with the following repeating unit: [3)-α-D-Fuc-(1→4)- α-L-Rha-(1→]n 
 
 O-Chain 1 
 
 
 
Fig. 3.2.  1H NMR spectrum of the product (O-Chain 1) obtained after basic hydrolysis (KOH 
4M). 
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Tab. 3.1. Chemical shifts of O-Chain 1. 
 
 
 
 
 
The second polymer is constituted from the amino acid N-methyl-3,4-dihydroxy-3-methyl-5-
oxoproline and from the sugar residue 4-deoxy-4-amino-3-O-methyl-α-D-Fucose; the 
monosaccharide is linked at O-4 of the modified amino acid that, in turn, it is linked at N-4 
of the successive amino sugar unit. The structure of this oxoproline derivative is new and it 
is found for the first time in bacterial LPS. 
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 Fig. 3.3. 1H spectrum of methyl-glycoside (anomeric mixture) 
 
 
 
 
Fig. 3.4.  13C spectrum of methyl-glycoside (anomeric mixture). 
 
 
 
The structure elucidation started from the anomeric protons, found at 4.79 ppm for the α-
anomer (3JH1,H2= 4.0 Hz) and 4.31 ppm for the β-anomer (3JH1,H2= 7.8 Hz). The recognition of 
all the ring protons obtained by COSY spectrum allowed the identification of the 6-deoxy 
nature of the sugar residue, while the small values of 3JH3,H4 (4.4 Hz) and 3JH4,H5 (2.0 Hz) 
coupling constants were in agreement with a galacto configuration for this spin system. 
The low field value of C-4 (51.6 and 51.3 ppm, 
respectively) indicated that this atom was 
linked to a nitrogen atom, whereas the higher 
chemical shift of C-3 (79.0 and 82.1 ppm, 
respectively) was diagnostic for an alkyl 
substituent O-3 linked. The circular dichroism 
(CD) exciton chirality method was applied to 
1.52.02.53.03.54.04.5 ppm
30405060708090100110120130140 150 160 170 ppm
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determine the absolute configuration of the sugar residue.  
 
Fig. 3.5.  Circular dichroism spectrum. 
 
Hydroxyl group was transformed into the corresponding ester and NH2 group was 
converted into the corresponding amide with 4-p-Br-benzoyl-chloride, upon which 
interactions between the electric transition moments of chromophores located nearby in 
space give rise to CD curves exhibiting split Cotton Effects. Inversion of the CD sign 
occurred at λ= 241 nm, while λmax was registered at 251.6 nm (Fig. 3.5). The positive Cotton 
Effect designated a clockwise arrangement of the two p-bromobenzoate chromophores, 
and consequentially a D-configuration was assigned. The 13C spectrum of the 
polysaccharide 2 (Fig. 3.4) contained, inter alia, signals for two C=O groups at 175.7 and 
172.5 ppm, and two methyls signals at 22.0 (C -CH3) and 30.3 ppm (N -CH3) correlated to 
the two signals at 1.40 and 2.70 ppm in 1H spectrum. Other information was obtained by 
proton signals at 4.51 ppm (13C = 76.7 ppm) and 4.11 ppm (α-anomer) or 4.13 ppm (β-
anomer), whose carbon signal was found at 72.2 ppm. No correlation was found in the 
HSQC spectrum for the carbon signal at 72.2 ppm, 
this was diagnostic for a quaternary carbon. 
Additional informations were added by analysis of 
HMBC spectrum: long range correlations (3JC,H) are 
showed in Fig. 3.6. Such structure was confirmed 
from GC-MS analysis (Fig. 3.7) and from NMR spectra 
registered in DMSO-d6 (Tab. 3.2). In Fig. 3.8 is 
reported the 1H NMR spectrum. Signals attributed to 
OH and NH groups are highlighted.   
 
 
Fig. 3.6.  Long range correlations. 
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Fig. 3.7. GC-MS  analysis of methyl-glycoside. 
 
 
 
 
Table 3.1. Chemical shifts of  α/β anomer in D2O. 
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Fig. 3.8. 1H NMR spectrum of methyl-glycoside.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.2. Chemical shifts of  α/β anomer in DMSO-d6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 4 
 
 
Lactobacillus crispatus B6 
 
 
4.1.  Lactic acid bacteria 
 
Lactic acid bacteria (LAB) are a group of related bacteria which have the property of 
converting lactose and other simple sugars to lactic acid by a process called 
fermentation. Some nutritional benefit gained from lactic acid include an improved 
nutritional value of food, control of intestinal infections, improved digestion of lactose and 
control of serum cholesterol levels. Bacteria belonging to this group are referred to as 
probiotics, which means in favour of life. Probiotics are defined as living microorganism 
that can be administered to promote the health of the host by treating or preventing 
diseases such as urinary tract infections (UTI)(51). An important criterion for a potential 
probiotic strain is its ability to adhere to the mucosal surfaces of the human gastrointestinal 
tract. Adhesion of probiotics to the intestinal mucosa can prolong the time that probiotics 
have effects on the microbiota balance of the host and the gastrointestinal immune 
system(52). The ability to 
adhere to the surface of 
human intestinal 
surfaces is thought to 
help in the colonization 
by the probiotics to 
create this balance. The 
genus Lactobacillus is an 
important member of 
this group. Lactobacilli 
are Gram-positive 
facultative anaerobe 
bacteria which vary in 
morphology from long rods to short coccobacilli. In humans they are normal inhabitants of 
the gastrointestinal tract and the urogenital tract(53,54). Some Lactobacillus strains using 
either the cells alone or in combination with their culture supernatants inhibit adhesion of 
pathogens, such as Escherichia coli K88 to porcine mucus(55-57).  
 
Fig. 4.1. Vaginal acquisition of HIV infection. The normal vaginal epithelium comprise a multi-cellular 
layer of stratified squamous epithelial cells. Cell-free virus can gain access to Langerhans cells  with 
dendritic surfaces that might extend near to, or into, the mucosal lumen(64). 
Lactobacilli used as probiotics have played an important role in preventing the 
colonization of pathogenic bacteria in the vagina(58). To date, 56 species of the genus 
Lactobacillus have been identified. Lactobacillus species are the predominant aerobes of 
the vaginal microflora.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.2.a.  Factors that can increase the risk of vaginal HIV infection: thinning of the squamous 
epithelial layer, bacterial vaginosis, vaginal drying, inflammation, trauma, ulcerative infections that 
might allow more ready access of virus to sub-epithelial dendritic cells(64).   
 
 
While all lactobacilli produce lactic acid, some lactobacilli also produce hydrogen 
peroxide (H2O2), a known antibacterial compound(59). Because of this activity, these strains 
are believed to act as endogenous microbicides in the vagina: they may protect against 
genital infection, including Neisseria gonorrhoeae, Chlamydia, Herpes simplex virus 2 and 
human immunodeficiency virus (HIV) infection(60,61). Disruption of the Lactobacillus-
dominated microbiota can lead to abnormal vaginal microbial communities associated 
with bacterial vaginosis, which develops with a concomitant rise in vaginal pH, and an 
increased incidence of urinary tract infections (UTI).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.2.b. Factors that might decrease the risk of infection with HIV: a thicker squamous epithelium, a 
mucous layer that physically traps virus, innate immune defence molecules (such as defensins, 
interferons) physical properties leading to HIV inactivation such as low pH and peroxides (for 
example, hydrogen peroxide) from Lactobacilli(64). 
 
 
The role of Lactobacilli in the maintenance of vaginal health was first recognized by 
Doderlein in the late 1800s: application of exogenous Lactobacillus was one of the first 
strategies used to treat gonorrhea. Recent studies have established that  L. crispatus and L. 
jensenii are two of the most commonly recovered vaginal species in women with a 
Lactobacillus predominant microflora(62). At present, a capsule containing L. crispatus has 
been developed for use in humans to promote and increase vaginal colonization by H2O2 
 producing Lactobacilli. Use of this probiotic as a new intravaginal agent is now being 
evaluated(63). The development of the L. crispatus capsule as a natural, probiotic 
microbicide offers several advantages for vaginal health. Therefore, the probiotic 
microbicide approach is unique in that it is focused on promoting innate defences of the 
vaginal ecosystem.  
The structural determination of the EPSs from this probiotic bacterium is the first step in 
understanding their function in protecting the host from harmful bacteria and viruses.  
 
 
 
 
           4.2.   RESULTS AND DISCUSSION 
 
Fermentation broth containing the crude exopolysaccharide material was ultrafiltrated 
and lyophilised. EPSs were precipitated by the addition of cold ethanol. The NMR spectrum 
of the supernatant showed it to be composed mainly of phospholipids, while the 
precipitate containing EPSs was  purified on Sephacryl S-400, obtaining two products. A 
Sephacryl S-300 gel-filtration chromatography was performed on the more retained 
fraction, obtaining three different peaks (LC/2/B) vedi fig. Peak 2 was further purified by 
water/phenol extraction. The water extract (EPS fraction) was analysed by GC-MS and 
NMR (Fig. 4.3-4.4).  
 
 
 
Fig. 4.3. GC-MS chromatogram of EPS fraction from Lactobacillus crispatus. 
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Fig. 4.4. 1H NMR spectrum of EPS fraction from Lactobacillus crispatus. 
 
The glycosyl composition indicated a monosaccharide composition consisting of 
differently linked mannose units suggesting a mannan structure. In particular, the 
methylation analysis showed the presence of terminal Manp, 2-substituted Manp, 3- 
substituted Manp, 6- substituted Manp and 2,6- substituted Manp. The absolute 
configuration of these sugars was determined to be D on the basis of the GLC analysis of 
their 2-octyl glycoside acetates. The 1H NMR  spectrum exhibited seven broad anomeric 1H 
singlets (Table 4.1), all attributable to mannose units.  
 
 
Tab. 4.1. Chemical shifts of EPS fraction from Lactobacillus crispatus. 
Residue 1 2 3 4 5 6 
1P-
Manp  5.435  4.001 3.913 3.802 3.700  
3.870, 
3.721 
 96.8  70.5  70.8  67.1 74.4 61.0 
2-
Manp  5.280  4.105 3.906 3.718 3.714  
3.870, 
3.721 
 101.2  79.3  71.0  67.4 75.4  61.8  
3-
Manp  5.159  4.209 3.881 
3.65 3.761  3.886, 3.736 
 103.2  71.1  79.1  66.0 75.3  62.0  
3-
Manp  5.137  4.226 3.876 
3.60 3.756  3.886, 3.736 
 103.2  71.1  79.1  66.1 75.6  62.0  
2,6-
Manp  5.105  4.027 3.932 
3.69 3.800  4.005, 3.701 
 99.2  79.6  71.5  67.8 74.6 67.6  
t-
Manp  5.037  4.059 3.860 3.663 3.754  
3.893, 
3.711 
 103.2  71.0  71.2  67.5 76.4 62.1  
t-
Manp  5.037  4.204 3.932 3.62 3.864  
3.893, 
3.711 
 103.2  70.1  70.7  67.9 76.4 62.1  
6-
Manp  4.889  3.981 3.818 3.708 
3.88 3.913, 
3.729 
 100.6  70.6  71.0  67.3 74.8 66.5  
1.01.52.2.53.3.4.04.55.5.5 pp
  
These values, together with the  3JH-2,H-3 and  1JC,H coupling constants, were diagnostic for 
an α-configuration of the sugar residues. The signal resonating at 5.435 ppm  in 1H NMR  
spectrum was correlated to a carbon signal at 96.8 ppm. Both values were in agreement 
with a phosphorylated mannose unit. The assignment of all spin resonance systems by 
means of COSY, TOCSY, NOESY, and HSQC experiments allowed to identify a α-(1→6)-
linked mannopyranan. Furthermore, in accordance with data reported in literature, these 
results suggested the presence of a highly branched, comb-like structure with 
mannopyranose units branched at C-2 with 2-substituted mannose residues. In order to 
confirm this hypothesis and to establish the length of the branches, an acetolysis reaction 
was performed on EPS fraction. The crude reaction mixture was separated by means of a 
TSK-40 gel-filtration chromatography, obtaining four fractions (1-4). Each fraction was 
subjected to chemical and spectroscopic analysis.  
 
 
 
Table 4.2 
Chemical
shift δ 
(1H/13C) 
1 2 3 4 5 6 
2-α-
Manp  5.36  3.93 3.77 3.67 3.77  3.873 
 92.9  79.7 73.6 67.5 74.2 61.4 
2-α-
Manp  5.28  4.10 3.94 3.68 3.76  3.873 
 100.9  79.3 70.5 67.5 74.2  61.4  
t-α-
Manp  5.13  4.06 3.87 
3.65 3.76  3.874 
 102.4  70.6 70.9 67.5 74.2  61.4  
3-α-
Manp  5.02  4.21 3.94 
3.74 3.77 3.874 
 102.6  69.9 78.5 66.9 73.4  61.4  
Table 4.3 
Chemical
shift δ 
(1H/13C) 
1 2 3 4 5 6 
2-α-
Manp  5.35 3.92 3.77 3.68 3.75  3.86  
 93.0  79.1 72.9 66.8 73.2 61.4 
2-α-
Manp  5.28  4.10 3.95 3.67 3.74  3.74 
 100.8 78.4 69.9 66.8 73.2  61.4  
t-α-
Manp  5.03  4.05 3.83 
3.63 3.76  3.86 
 101.9  70.0 70.4 66.8 73.2  61.4  
Table 4.4 
Chemical
shift δ 
(1H/13C) 
1 2 3 4 5 6 
2-α-
Manp  5.36  3.93 3.77 3.67 3.77  3.87 
 93.0 78.9 73.6 67.5 74.5  61.4  
t-α-
Manp  5.03  3.99 3.87 
3.66 3.76  3.74 
 101.9  70.0 70.5 66.8 74.5  61.4  
Tab. 4.2-4.4  Chemical shifts of polysaccharides obtained from acetolysis reaction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fraction 1 consisted of a mannose tetrasaccharide, the structure of which is the following: 
α-D-Manp-(1→3)-α-D-Manp-(1→2)-α-D-Manp-(1→2)- D-Man.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.5. 1H NMR spectrum of tetrasaccharide. 
Fraction 2 was found to be a trisaccharide α-D-Manp-(1→2)-α-D-Manp-(1→2)- D-Man, 
while fraction 3 consisted of the disaccharide D-Manp-(1→2)- D-Man. 
3.4 3.63.84.04.24.44.64.8 5.05.2 5.4 ppm 
  
 
 
Fig.4.6. 1H NMR spectrum of trisaccharide. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.7. 1H NMR spectrum of disaccharide. 
 
 
 
 
Fraction 4 was composed by mannose monosaccharides. Hence, a general formula for 
this complex exopolysaccharide can be represented as follows: 
 
 
      [→6)α-D-Manp-(1→6)-α-D-Manp-(1→6)-α-D-Manp-(1→6)-α- D-Manp-(1→]n 
3.43.6 3.8 4.04.24.44.64.8 5.05.2 5.4 
ppm
3 43 63 84 04 24 44 64 85 05 25 4 ppm
 2 2 2  
 ↑ ↑ ↑ 
 1 1 1 
α-D-Manp  α-D-Manp  α-D-Manp 
                                       2 2  
                                       ↑ ↑  
                                       1 1  
                                 α-D-Manp α-D-Manp  
 3 
 ↑ 
 1 
 α-D-Manp 
 
 
 
The oligosaccharides side chains can be linked to whichever mannose residue of the 
mannan backbone. It was not possible to find out the positions that each side chain holds 
along the main chain, since the true sequence of this EPS doesnt have a well defined 
repeating unit but possesses an extremely random one.    
 
 
 
4.3.  Experimental Section 
 
4.3.1. Purification of EPSs 
 
50mL of ultrafiltrated fermentation broth were lyophilised leading to a yield of 600mg of 
crude exopolysaccharide material. The native EPS was dissolved in 12 mL of water and 
allowed to precipitate with three volumes of cold ethanol overnight at 4°C. The 
precipitate was collected by centrifugation (7000 rpm, 15 min, 4°C, yield 277mg) and 
identified as mannan by chemical composition and NMR analysis (EPS fraction). The 
supernatant(yield 320mg) resulted to be composed mainly of phospholipids and it was not 
considered further. EPS fraction was applied to a column of Sephacryl S-400 (GE 
Healthcare, 1,5 x  87 cm), eluted with 50mM NH4HCO3 at a flow rate of 20 mL/h at room 
temperature. The eluate was monitored with a R.I. refractometer (K-2310 Knauer) and 4 mL 
fractions were collected. Two fractions were obtained; the more retained fraction 
(yield140 mg) was further purified by means of a Sephacryl S-300 column (GE Healthcare, 
1,5 x  70 cm), eluted with 50mM NH4HCO3 at a flow rate of 20 mL/h at room temperature. 
Three peaks were collected and subjected to chemical and spectroscopic analysis. Peak 
2 (figure) (yield 98 mg) was purified according to the hot phenol/water method. An 
aliquot of water phase (yield 90 mg) was used for the acetolysis reaction.  
 
 
4.3.2. Acetolysis of mannan 
 
In order to selectively cleave 6-linked sugars, an acetolysis reaction on 50 mg of product 
was performed as reported. The deacetylated products (yield 40mg) were separated on a 
Toyopearl TSK HW-40 column (1,5 x 95 cm,  flow rate 7 mL/h, NH4HCO3 as eluent) and 
monitored with a R.I. refractometer (K-2310 Knauer). Four peaks were detected and 
analysed by methylation analysis and NMR.  
 
 
4.3.3. NMR spectroscopy 
 
The 1H and 13C  NMR spectra were obtained in D2O at 400 and 100 MHz, respectively, with 
a Bruker DRX 400 spectrometer equipped with a reverse probe, in the FT mode at 27°C. 
Spectra were calibrated with internal acetone [δH 2.225, δC 31.45]. Two dimensional 
spectra (COSY, TOCSY, ROESY, HSQC and HMBC) were measured using standard Bruker 
software.  
4.3.4.  Compositional and methylation analysis 
 
1 mg of sample was methanolysed with 1 mL of 1 M HCl/MeOH at 80°C overnight, dried 
under reduced pressure and then acetylated with 100 µL of acetic anhydride in 200 µL of 
pyridine (80°C, 40 min). After work-up, the sample was analysed by GLC-MS on an Hewlett-
Packard 5890 instrument, SPB-1 capillary column (Supelco, 30 m x 0.25 mm i.d., flow rate 
0.8 mL/min, He as carrier gas) with the following temperature program: 150°C 3min, then 
up to 300°C at 10°C/min). Absolute configurations were determined by GLC of acetylated 
glycosides of (+)-2-octanol as reported.  
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